Learn / URGN
NASDAQ: URGN
UroGen Pharma Ltd. (URGN) stock, explained like you're 5
UroGen Pharma Ltd. trades on the Nasdaq under the ticker URGN. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 1.8 billion dollars.
- Ticker
- URGN
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Small cap, about 1.8 billion dollars
Is UroGen Pharma Ltd. a small, medium or large cap company?
No. UroGen Pharma Ltd. is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 1.8 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How UroGen Pharma Ltd. makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves URGN stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- UroGen Pharma Ltd (UR8.MU) stock price, news, quote and history (Yahoo Finance UK)
- UroGen Pharma (Nasdaq:URGN) Stock Analysis (Simply Wall Street)
- UroGen Pharma: An Emerging GARP Stock (Seeking Alpha)
- URGN Stock Jumps As Street Hikes Targets On Patent Wins (Timothy Sykes)
- $URGN stock is down 13% today. Here's what we see in our data. (Quiver Quantitative)
Follow URGN in your daily brief
Each trading day at 5 PM ET we post what happened to UroGen Pharma Ltd. and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow URGN
Questions about UroGen Pharma Ltd. stock
What does UroGen Pharma Ltd. do?
UroGen Pharma Ltd. trades on the Nasdaq under the ticker URGN. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 1.8 billion dollars.
What is the ticker symbol for UroGen Pharma Ltd.?
UroGen Pharma Ltd. trades under the ticker URGN on the Nasdaq.
What is UroGen Pharma Ltd.'s market cap?
UroGen Pharma Ltd. is a small cap stock with a market cap of about 1.8 billion dollars.
How does UroGen Pharma Ltd. make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves URGN stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow URGN stock every day?
Add URGN to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.